Skip to main content
. 2021 May 2;9(5):446. doi: 10.3390/vaccines9050446

Table 3.

Univariate and Multivariate Analyses of Factors Affecting Hesitancy.

Variable Levels Acceptance (%) Hesitancy (%) Univariable OR (CI) Multivariable OR (CI)
Age <30 813 (26.8) 2220 (73.2)
30–39 460 (27.9) 1189 (72.1) 0.95 (0.83–1.08) 1.21 (1.03–1.42)
40–49 178 (25.7) 514 (74.3) 1.06 (0.88–1.28) 1.41 (1.14–1.75)
50–59 52 (19.9) 209 (80.1) 1.47 (1.08–2.03) 1.92 (1.37–2.73)
>59 19 (26.0) 54 (74.0) 1.04 (0.62–1.81) 1.62 (0.93–2.94)
Chronic Diseases No 1321 (26.9) 3587 (73.1)
Yes 201 (25.1) 599 (74.9) 1.10 (0.93-1.31) 1.01 (0.84–1.22)
Country Arab countries 1289 (25.8) 3707 (74.2)
Other countries 233 (32.7) 479 (67.3) 0.71 (0.60–0.85) 0.87 (0.73-1.05)
Academic Education Higher education 1045 (27.0) 2830 (73.0)
Lower education 477 (26.0) 1356 (74.0) 1.05 (0.93–1.19) 0.97 (0.84–1.14)
Had Covid No 754 (29.2) 1825 (70.8)
Not sure 468 (25.2) 1391 (74.8) 1.23 (1.07-1.41) 1.25 (1.08–1.44)
Yes 300 (23.6) 970 (76.4) 1.34 (1.15–1.56) 1.34 (1.14-1.58)
Gender Male 1049 (33.1) 2122 (66.9)
Female 473 (18.6) 2064 (81.4) 2.16 (1.91–2.44) 2.04 (1.79–2.32)
Vaccine Type Unknown No 1173 (30.4) 2684 (69.6)
Yes 349 (18.9) 1502 (81.1) 1.88 (1.64–2.16) 1.69 (1.47–1.96)
Influenza Vaccine Yearly 178 (55.5) 143 (44.5)
Some years 279 (41.0) 402 (59.0) 1.79 (1.37–2.35) 1.70 (1.29–2.24)
Rarely 210 (29.5) 502 (70.5) 2.98 (2.27–3.91) 2.87 (2.17–3.81)
Never 855 (21.4) 3139 (78.6) 4.57 (3.62–5.77) 4.30 (3.37–5.49)